MedTrace Logo

A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Rewetting Drops in Subjects With History and Current Complaint of Contact Lens-Related Dry Eye (CLDE)

NCT01105624 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2011-09-26

No results posted yet for this study

Summary

The primary objective of this study is to compare the duration of subject reported comfortable contact lens daily wear time in subjects with a history and current complaint of CLDE during a 29-day treatment period of azithromycin ophthalmic solution, 1%, compared to rewetting drops

Conditions

  • Contact Lens Dry Eye

Interventions

DRUG

azithromycin ophthalmic solution, 1%

1 drop BID for the first 2 days and then 1 drop QD for the remainder of treatment period (29 ± 1 day)

DRUG

Visine® for Contacts®

1-2 drops QID for the treatment period (29 ± 1 day)

Sponsors & Collaborators

Principal Investigators

  • Reza Haque, MD, PhD · Medical Monitor

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2010-11-30
Completion
2010-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01105624 on ClinicalTrials.gov